|
Volumn 21, Issue 4, 2007, Pages 213-215
|
Retinal angiomatous proliferation and intravitreal bevacizumab injection.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
AGED;
ARTICLE;
EYE FUNDUS;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
FOLLOW UP;
HUMAN;
INJECTION;
MALE;
MIDDLE AGED;
PATHOLOGY;
RETINA NEOVASCULARIZATION;
TREATMENT OUTCOME;
VISUAL ACUITY;
VITREORETINOPATHY;
VITREOUS BODY;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
FOLLOW-UP STUDIES;
FUNDUS OCULI;
HUMANS;
INJECTIONS;
MALE;
MIDDLE AGED;
RETINAL NEOVASCULARIZATION;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREORETINOPATHY, PROLIFERATIVE;
VITREOUS BODY;
|
EID: 41649101484
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2007.21.4.213 Document Type: Article |
Times cited : (10)
|
References (0)
|